Related Experiment Video
Updated: May 6, 2026

08:02
Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
13.0K
High Throughput Intracellular Delivery Using a 2D Cell-Squeezing Mechanoporation Device and Its Analysis by a Deep
Pulasta Chakrabarty1, Abinaya R1, Ryoma Suzuki2
1Department of Engineering Design, Indian Institute of Technology Madras, Chennai, Tamil Nadu, 600036, India.
Advanced Healthcare Materials
|August 21, 2025
Summary
A novel 2D microfluidic device enhances cell-squeezing mechanoporation for high-throughput intracellular delivery. This technology efficiently delivers molecules like dextran and siRNA into various cell types, enabling advanced research and therapeutic applications.
Area of Science:
- Biotechnology
- Microfluidics
- Cell Biology
Background:
- Cell-squeezing mechanoporation offers intracellular delivery but faces throughput limitations with 1D constrictions.
- Developing high-throughput methods is crucial for advancing single-cell delivery applications.
Purpose of the Study:
- To design and fabricate a 2D microfluidic device for parallel, high-throughput cell-squeezing mechanoporation.
- To demonstrate efficient intracellular delivery of various molecules into diverse cell types using the novel device.
Main Methods:
- Fabrication of a 2D microfluidic device with an array of vertical through-holes (8-15 µm diameter) on a thin SU-8 membrane within a PDMS structure.
- Intracellular delivery via rapid cell shearing through microfluidic constrictions, enabling diffusion-based molecule uptake.
- Analysis of delivery efficiency using image cytometry, combining instance segmentation and rule-based image processing for automated single-cell state evaluation.
Main Results:
- Achieved high-throughput dextran (4-40 kDa) delivery into HeLa and Jurkat cells at rates up to 3 million cells/min.
- Successfully delivered small interfering ribonucleic acid (siRNA) and plasmids into primary human mesenchymal stem cells (hMSCs) and human gingival fibroblasts (hGFs).
- Automated deep learning-based analysis system enabled single-cell resolution quantification of mechanoporation-based intracellular delivery.
Conclusions:
- The 2D cell-squeezing microfluidic device significantly increases throughput for intracellular delivery compared to 1D methods.
- The platform demonstrates broad applicability for delivering molecules and genetic material into various cell types, including primary cells.
- The integrated automated analysis system provides precise, single-cell resolution quantification, validating the device's potential for therapeutic applications.

